Bio-Techne Corporation
TECH
Classement en actions
#1864
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Prix de l'action
$72.49
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$11.37B
Changement (1 jour)
-0.12%
Changement (1 an)
15.90%
Pays
US
Échange Bio-Techne Corporation (TECH)
Catégorie
Healthcare
Nombre d'actions en circulation pour Bio-Techne Corporation (TECH)
Nombre d'actions en circulation au June 2026: 155.96M
Selon les derniers rapports financiers et le cours de l'action de Bio-Techne Corporation, le nombre actuel d'actions en circulation est de 155.96M. À la fin de June 2024, l'entreprise avait 157.71M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Bio-Techne Corporation (TECH) de 2000 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 155.96M | -0.99% |
| 2025 | 157.52M | -0.12% |
| 2024 | 157.71M | 0.34% |
| 2023 | 157.18M | 0.19% |
| 2022 | 156.88M | 1.22% |
| 2021 | 154.99M | 1.43% |
| 2020 | 152.80M | 1.11% |
| 2019 | 151.12M | 0.81% |
| 2018 | 149.90M | 0.44% |
| 2017 | 149.25M | 0.32% |
| 2016 | 148.78M | 0.26% |
| 2015 | 148.38M | 0.56% |
| 2014 | 147.56M | 0.15% |
| 2013 | 147.34M | -0.28% |
| 2012 | 147.76M | -0.43% |
| 2011 | 148.39M | -0.42% |
| 2010 | 149.02M | -1.45% |
| 2009 | 151.21M | -3.42% |
| 2008 | 156.56M | -0.68% |
| 2007 | 157.62M | 0.91% |
| 2006 | 156.20M | -3.25% |
| 2005 | 161.44M | -1.67% |
| 2004 | 164.18M | -0.78% |
| 2003 | 165.48M | -0.33% |
| 2002 | 166.03M | 0.17% |
| 2001 | 165.75M | 2.00% |
| 2000 | 162.50M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 62.80% |
US
|
|
| 396.00M | 153.91% |
US
|
|
| 478.91M | 207.07% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -60.13% |
NL
|
